Tag: SBUX

Analysts fell to the sidelines weighing in on Starbucks (SBUX – Research Report) and DR Horton (DHI – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.

Starbucks (SBUX)

Oppenheimer analyst Brian Bittner maintained a Hold rating on Starbucks today. The company’s shares closed last Thursday at $87.15, close to its 52-week low of $84.29.

According to TipRanks.com, Bittner is a 5-star analyst with an average return of 10.6% and a 64.5% success rate. Bittner covers the NA sector, focusing on stocks such as Restaurant Brands International, Yum China Holdings, and BJ’s Restaurants.

Starbucks has an analyst consensus of Moderate Buy, with a price target consensus of $104.96, which is a 21.4% upside from current levels. In a report issued on April 11, Stifel Nicolaus also maintained a Hold rating on the stock with a $90.00 price target.

See today’s best-performing stocks on TipRanks >>

DR Horton (DHI)

In a report released today, Tyler Batory from Oppenheimer maintained a Hold rating on DR Horton. The company’s shares closed last Thursday at $145.88.

According to TipRanks.com, Batory is a 4-star analyst with an average return of 7.4% and a 59.4% success rate. Batory covers the NA sector, focusing on stocks such as Braemar Hotels & Resorts, Apple Hospitality REIT, and Xenia Hotels & Resorts.

DR Horton has an analyst consensus of Moderate Buy, with a price target consensus of $168.33.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on SBUX:

• Starbucks price target lowered to $94 from $100 at Jefferies
• Brinker price target raised to $48 from $47 at Jefferies
• Starbucks price target lowered to $115 from $120 at Morgan Stanley
• Starbucks price target lowered to $95 from $102 at Citi
• Starbucks price target lowered to $90 from $102 at Stifel